Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New gum repair gel takes on gold standard in Tooth-Saving showdown

NCT ID NCT07430748

Disease control Sponsor: University of Santiago de Compostela Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-phase study tests whether a new biomaterial (REGENFAST) works better than a standard platelet-based treatment (L-PRF) for repairing gum and bone damage caused by gum disease. Fifteen adults with matching defects on both sides of the mouth will receive one treatment on each side, and healing will be compared over 3 months. The goal is to see which material better restores tooth support and improves gum health.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Early phase 1

The earliest testing in people: a first look at safety, in a very small group.

Participants

About 15 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

May 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients (≥18 years old) in good general health (ASA I-II). * Bilateral gingival recessions or symmetrical bone defects. * Absence of active infection or inflammation. * Good oral hygiene level (Plaque Index \<20%). * Signed informed consent and commitment to follow-up. Exclusion Criteria: * Systemic diseases that impair healing (uncontrolled diabetes, immunodeficiency, etc.). * Periodontal or antibiotic treatment within the last 6 months. * Smokers (\>10 cigarettes/day). * Pregnancy or breastfeeding. * Allergy or hypersensitivity to REGENFAST® or surgical materials. * Use of medication affecting healing (corticosteroids, immunosuppressants, bisphosphonates). * Lack of availability to attend follow-up visits.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Biomaterials are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

periodontal disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Biomaterials Periodontal defects Regeneration

Contacts and locations

Locations

  • Facultade de Odontoloxía

    Santiago de Compostela, A Coruña, 15782, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.